Application 203016

Type
ANDA
Sponsor
TORRENT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOLTERODINE TARTRATETOLTERODINE TARTRATECAPSULE, EXTENDED RELEASE;ORAL2MGNoNo
002TOLTERODINE TARTRATETOLTERODINE TARTRATECAPSULE, EXTENDED RELEASE;ORAL4MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0904-6592TOLTERODINE TARTRATETOLTERODINEMajor PharmaceuticalsANDACurrent
0904-6592TOLTERODINE TARTRATETOLTERODINEMajor PharmaceuticalsANDACurrent
0904-6592TOLTERODINE TARTRATETOLTERODINEMajor PharmaceuticalsANDACurrent
0904-6593TOLTERODINE TARTRATETOLTERODINEMajor PharmaceuticalsANDACurrent
0904-6593TOLTERODINE TARTRATETOLTERODINEMajor PharmaceuticalsANDACurrent
0904-6593TOLTERODINE TARTRATETOLTERODINEMajor PharmaceuticalsANDACurrent
13668-189TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-189TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-189TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-189TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-190TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-190TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-190TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
13668-190TOLTERODINE TARTRATETOLTERODINETorrent Pharmaceuticals LimitedANDACurrent
60687-319Tolterodine TartrateTolterodineAmerican Health PackagingANDACurrent
60687-319Tolterodine TartrateTolterodineAmerican Health PackagingANDACurrent
60687-319Tolterodine TartrateTolterodineAmerican Health PackagingANDACurrent
60687-330Tolterodine TartrateTolterodineAmerican Health PackagingANDACurrent
60687-330Tolterodine TartrateTolterodineAmerican Health PackagingANDACurrent
60687-330Tolterodine TartrateTolterodineAmerican Health PackagingANDACurrent